Ancor Capital cashes out of WellSpring Pharma Services
U.S. private equity firm Ancor Capital Partners has sold its interest in WellSpring Pharma Services Inc, an Oakville, Ontario-based pharmaceutical contract manufacturing organization operating across North America. Wellspring was sold earlier this month to ANI Pharmaceuticals Inc (Nasdaq: ANIP) for US$18 million in cash, PE Hub Canada previously reported. Ancor and Sentinel Capital Partners together acquired WellSpring in 2011. Sentinel also exited with the sale.
14 August 2018•3 mins read
